Yakira Capital Management, Inc.
Position in ESLA — Estrella Immunopharma, Inc.
CIK 1584639
Westport, CT
Position in ESLA
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
46,285
-0.4% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESLA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Yakira Capital Management, Inc. holds $1,693,243 across 7 Biotechnology names. ESLA ranks #2 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RNA |
Atrium Therapeutics, Inc.
|
126,645 | $1,693,243 | |
| 2 | ESLA |
Estrella Immunopharma, Inc.
This page
|
46,285 | $0 | |
| 3 | KZR |
Kezar Life Sciences, Inc.
|
24,000 | $0 | |
| 4 | TVGN |
Tevogen Bio Holdings Inc.
|
65,128 | $0 | |
| 5 | CNTA |
Centessa Pharmaceuticals plc
|
24,000 | $0 | |
| 6 | ACLX |
Arcellx, Inc.
|
24,000 | $0 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,000 | $0 |
All Filings in ESLA
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 ESLAW | — | 46,285 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 ESLAW | — | 46,485 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 ESLAW | — | 46,485 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 ESLAW | — | 46,485 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 ESLAW | — | 46,485 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 ESLAW | — | 46,485 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 ESLAW | — | 46,485 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 ESLAW | — | 46,485 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 ESLAW | — | 46,485 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 ESLAW | — | 46,485 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||